More than 50 million people worldwide live with epilepsy, with approximately half of them being children. For about one-third of these patients, medications do not control their seizures, leaving surgery as the only viable option for seizure relief.
Empress Therapeutics emerges with $50m to fund small molecule development – Pharmaceutical Technology
The Chemilogics platform benefits from a wealth of clinical data, and recent advances in genomics, AI and synthetic biology. Source: Shutterstock / metamorworks Life sciences